Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 11, 2025 08:00 ET | Source: SharpLink Gaming, Inc.

SharpLink’s ETH Holdings Expected to Exceed $3 Billion Following $400 Million Registered Direct Offering with Institutional Investors

MINNEAPOLIS, MN, Aug. 11, 2025 (GLOBE NEWSWIRE) -- SharpLink Gaming, Inc. (Nasdaq: SBET) (“SharpLink” or the “Company”) today announced that it has entered into securities purchase agreements for an...
May 27, 2025 08:00 ET | Source: SharpLink Gaming, Inc.

SharpLink Gaming Announces $425,000,000 Private Placement to Initiate Ethereum Treasury Strategy

SharpLink continues its online performance-based marketing company serving the U.S. sports betting and global iGaming industries Upon the closing of the Private Placement, SharpLink will adopt an...
January 25, 2024 09:38 ET | Source: Jeffs' Brands Ltd

Jeffs’ Brands Announces Pricing of $7.275 Million Private Placement

Tel Aviv, Israel, Jan. 25, 2024 (GLOBE NEWSWIRE) -- Jeffs’ Brands Ltd (“Jeffs’ Brands” or the “Company”) (Nasdaq: JFBR, JFBRW), a data-driven e-commerce company operating on the Amazon Marketplace,...
July 14, 2021 16:15 ET | Source: CurrencyWorks Inc

CurrencyWorks Announces Closing of US$3.75 Million Registered Direct Offering

Los Angeles, CA, July 14, 2021 (GLOBE NEWSWIRE) -- CurrencyWorks Inc. (“CurrencyWorks” or the “Company”), (CSE: CWRK and OTCQB: CWRK), a full service blockchain platform provider, today announced...
July 11, 2021 21:29 ET | Source: CurrencyWorks Inc

CurrencyWorks Announces $3.75 Million Registered Direct Offering

Los Angeles, CA, July 11, 2021 (GLOBE NEWSWIRE) -- CurrencyWorks Inc. (“CurrencyWorks” or the “Company”), (CSE: CWRK and OTCQB: CWRK), a blockchain pioneer, NFT, and digital payment provider, today...
February 10, 2021 23:00 ET | Source: Cancer Genetics, Inc.

Cancer Genetics Announces $17.5 Million Common Stock Offering Priced At-the-Market under Nasdaq Rules

RUTHERFORD, N.J., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (the “Company”) (Nasdaq: CGIX), a leader in drug discovery and preclinical oncology and immuno-oncology services, today...